Literature DB >> 28034695

Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.

Michael F Beers1, Lars Knudsen2, Yaniv Tomer1, Julian Maronn3, Ming Zhao1, Matthias Ochs4, Surafel Mulugeta5.   

Abstract

The lipid transporter, ATP binding cassette class A3 (ABCA3), plays a critical role in the biogenesis of alveolar type 2 (AT2) cell lamellar bodies (LBs). A relatively large number of mutations in the ABCA3 gene have been identified in association with diffuse parenchymal lung disease (DPLD), the most common of which is a missense mutation (valine substitution for lysine at residue 292 (ABCA3E292V)) that leads to functional impairment of the transporter in vitro. The consequences of ABCA3E292V gene expression in vivo are unknown. To address this question, we developed mouse models expressing ABCA3E292V knocked-in to the endogenous mouse locus. The parental (F1) mouse line (mAbca3E292V) that retained an intronic pgk-Neo selection cassette (inserted in reverse orientation) (mAbca3E292V-rNeo) demonstrated an allele dependent extracellular surfactant phospholipid (PL) deficiency. We hypothesize that this PL deficiency leads to aberrant parenchymal remodeling contributing to the pathophysiology of the DPLD phenotype. Compared to wild type littermates, baseline studies of mice homozygous for the pgk-Neo insert (mAbca3E292V-rNeo+/+) revealed nearly 50% reduction in bronchoalveolar lavage (BAL) PL content that was accompanied by quantitative reduction in AT2 LB size with a compensatory increase in LB number. The phenotypic alteration in surfactant lipid homeostasis resulted in an early macrophage predominant alveolitis which peaked at 8 weeks of age. This was followed by age-dependent development of histological DPLD characterized initially by peribronchial inflammatory cell infiltration and culminating in both an emphysema-like phenotype (which included stereologically quantifiable reductions in both alveolar septal surface area and volume of septal wall tissue) plus foci of trichrome-positive collagen deposition together with substantial proliferation of hyperplastic AT2 cells. In addition to spontaneous lung remodeling, mABCA3E292V-rNeo mice were rendered more vulnerable to exogenous injury. Three weeks following intratracheal bleomycin challenge, mAbca3-rNeo mice demonstrated allele-dependent susceptibility to bleomycin including enhanced weight loss, augmented airspace destruction, and increased fibrosis. Removal of the rNeo cassette from mAbca3 alleles resulted in restoration of BAL PL content to wild-type levels and an absence of changes in lung histology up to 32 weeks of age. These results support the importance of surfactant PL homeostasis as a susceptibility factor for both intrinsic and exogenously induced lung injury/remodeling.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ABCA3; Lamellar bodies; Lung disease; Pathogenesis; Phospholipids; Pulmonary; Surfactant

Mesh:

Substances:

Year:  2016        PMID: 28034695      PMCID: PMC5579840          DOI: 10.1016/j.aanat.2016.11.015

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  68 in total

Review 1.  Quantitative microscopy of the lung: a problem-based approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract.

Authors:  Christian Mühlfeld; Matthias Ochs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-24       Impact factor: 5.464

2.  Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations.

Authors:  Ralph Epaud; Céline Delestrain; Malek Louha; Stéphanie Simon; Pascale Fanen; Abdellatif Tazi
Journal:  Eur Respir J       Date:  2013-10-17       Impact factor: 16.671

3.  Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.

Authors:  Koji Kuronuma; Hiroaki Mitsuzawa; Katsuyuki Takeda; Chiaki Nishitani; Edward D Chan; Yoshio Kuroki; Mari Nakamura; Dennis R Voelker
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

Review 4.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

5.  Immunomodulation by pulmonary surfactant.

Authors:  A Catanzaro; P Richman; S Batcher; M Hallman
Journal:  J Lab Clin Med       Date:  1988-12

6.  ABCA3 mutations led to pulmonary fibrosis and emphysema with pulmonary hypertension in an 8-year-old girl.

Authors:  Chiharu Ota; Masato Kimura; Shigeo Kure
Journal:  Pediatr Pulmonol       Date:  2016-01-18

7.  Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease.

Authors:  Yoshihiro Matsumura; Nobuhiro Ban; Nobuya Inagaki
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

8.  Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.

Authors:  Hiroshi Kitazawa; Kunihiko Moriya; Hidetaka Niizuma; Kengo Kawano; Yuka Saito-Nanjo; Toru Uchiyama; Takeshi Rikiishi; Yoji Sasahara; Osamu Sakamoto; Yasuhiro Setoguchi; Shigeo Kure
Journal:  Eur J Pediatr       Date:  2013-02-27       Impact factor: 3.183

9.  Null ABCA3 in humans: large homozygous ABCA3 deletion, correlation to clinical-pathological findings.

Authors:  Paola Carrera; Maurizio Ferrari; Silvia Presi; Luisa Ventura; Barbara Vergani; Valeria Lucchini; Paola E Cogo; Virgilio P Carnielli; Marco Somaschini; Paolo Tagliabue
Journal:  Pediatr Pulmonol       Date:  2014-01-14

10.  Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study.

Authors:  K Zhang; M D Rekhter; D Gordon; S H Phan
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

View more
  11 in total

Review 1.  Is Progression of Pulmonary Fibrosis due to Ventilation-induced Lung Injury?

Authors:  Richard K Albert; Bradford Smith; Carrie E Perlman; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 2.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 3.  Familial Interstitial Lung Disease.

Authors:  Jonathan A Kropski
Journal:  Semin Respir Crit Care Med       Date:  2020-04-12       Impact factor: 3.119

4.  Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis.

Authors:  Shin-Ichi Nureki; Yaniv Tomer; Alessandro Venosa; Jeremy Katzen; Scott J Russo; Sarita Jamil; Matthew Barrett; Vivian Nguyen; Meghan Kopp; Surafel Mulugeta; Michael F Beers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

5.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

Review 6.  Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation.

Authors:  Amanda B Chai; Alaina J Ammit; Ingrid C Gelissen
Journal:  Respir Res       Date:  2017-02-28

Review 7.  Alveolar lipids in pulmonary disease. A review.

Authors:  Christina W Agudelo; Ghassan Samaha; Itsaso Garcia-Arcos
Journal:  Lipids Health Dis       Date:  2020-06-03       Impact factor: 3.876

Review 8.  Senescence in Pulmonary Fibrosis: Between Aging and Exposure.

Authors:  Alessandro Venosa
Journal:  Front Med (Lausanne)       Date:  2020-11-12

9.  The common ABCA3E292V variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling.

Authors:  Yaniv Tomer; Jennifer Wambach; Lars Knudsen; Ming Zhao; Luis R Rodriguez; Aditi Murthy; Frances V White; Alessandro Venosa; Jeremy Katzen; Matthias Ochs; Aaron Hamvas; Michael F Beers; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-16       Impact factor: 6.011

Review 10.  Stereology as the 3D tool to quantitate lung architecture.

Authors:  Lars Knudsen; Christina Brandenberger; Matthias Ochs
Journal:  Histochem Cell Biol       Date:  2020-10-13       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.